bicalutamide and its Impurities
Bicalutamide was patented in 1982 and approved for medical use in 1995. It is sold under the brand name Casodex among others, is an antiandrogen medication that is primarily used to treat prostate cancer.. Reference standards of Bicalutamide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below


Bicalutamide Related Compound A (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl (1071213)
Bicalutamide Related Compound A (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl (1071213)
Catalogue No.:PA USP1071213
CAS :
NA
Molecular Formula : NA
Molecular Weight : NA


Bicalutamide Related Compound B ((RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(3-fluorophenylsulfon (1071224)
Bicalutamide Related Compound B ((RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(3-fluorophenylsulfon (1071224)
Catalogue No.:PA USP1071224
CAS :
NA
Molecular Formula : NA
Molecular Weight : NA


(S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-((R)-(4-fluorophenyl)sulfinyl)-2-hydroxy-2-methylpropanamide
(S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-((R)-(4-fluorophenyl)sulfinyl)-2-hydroxy-2-methylpropanamide
Catalogue No.:PA 02 36590
CAS :
NA
Molecular Formula : C18H14F4N2O3S
Molecular Weight : 414.37


(R)-N-(4-cyano-3-(Trifluoromethyl)phenyl)-3-((S)-(4-fluorophenyl)sulfinyl)-2-hydroxy-2-methylpropanamide
(R)-N-(4-cyano-3-(Trifluoromethyl)phenyl)-3-((S)-(4-fluorophenyl)sulfinyl)-2-hydroxy-2-methylpropanamide
Catalogue No.:PA 02 0361001
CAS :
1080647-26-2
Molecular Formula : C18H14F4N2O3S
Molecular Weight : 414.37